DVYSR.ST STO
Devyser Diagnostics AB (publ)
1W: +6.0%
1M: -8.1%
3M: -5.8%
YTD: -48.8%
1Y: -62.8%
3Y: -27.7%
kr 54.10 ($5.39)
-0.70 (-1.28%)
Weekly Expected Move ±4.9%
kr 49
kr 52
kr 55
kr 57
kr 60
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$250M
+15.5% ▲
5Y CAGR: +30.7%
Gross Profit
$202M
+16.9% ▲
5Y CAGR: +28.9%
Operating Income
$11M
+118.2% ▲
Net Income
-$8M
+86.3% ▲
EPS (Diluted)
$-0.51
+86.4% ▲
EBITDA
$38M
+220.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $93M | $127M | $169M | $217M | $250M |
| YoY Growth | +42.3% | +35.4% | +33.7% | +28.1% | +15.5% |
| Cost of Revenue | $19M | $21M | $21M | $44M | $49M |
| Gross Profit | $75M | $106M | $148M | $173M | $202M |
| Gross Margin | 79.9% | 83.5% | 87.5% | 79.6% | 80.6% |
| R&D Expenses | $21M | $29M | $41M | $43M | $18M |
| SG&A Expenses | $76M | $132M | $164M | $193M | $173M |
| Operating Expenses | $96M | $161M | $205M | $231M | $191M |
| Operating Income | -$22M | -$55M | -$56M | -$58M | $11M |
| Operating Margin | -23.3% | -43.4% | -33.4% | -26.9% | 4.2% |
| Interest Expense | $939K | $500K | $800K | $4M | $14M |
| Income Before Tax | -$22M | -$53M | -$54M | -$58M | -$3M |
| Tax Expense | -$1M | -$7M | -$800K | $4M | $6M |
| Net Income | -$21M | -$46M | -$54M | -$62M | -$8M |
| Net Margin | -22.2% | -36.3% | -31.7% | -28.4% | -3.4% |
| EPS (Diluted) | $-1.85 | $-2.89 | $-3.31 | $-3.75 | $-0.51 |
| EBITDA | -$18M | -$46M | -$44M | -$31M | $38M |
| Shares Outstanding | 11M | 16M | 16M | 16M | 17M |